Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918658 · ClinicalTrials.gov registry record
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 34
- Enrollment target
NCT00918658 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 34 participants.
The verdict
NCT00918658 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 34 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors find better ways to treat the cancer. PURPOSE: This research study is looking at natural killer cells in bone marrow and blood samples from patients with hematologic cancer and from patients who do not have cancer.
Interventions
- OTHER biologic sample preservation procedure
- OTHER laboratory biomarker analysis
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918658
The ClinicalTrials.gov registry entry for NCT00918658 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which biologic sample preservation procedure is the first listed.
NCT00918658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918658 about?
NCT00918658 is a clinical study titled "Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer". RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors find better ways to treat the cancer. PURPOSE: This research study is looking at natural killer cells in bone marrow and blood samples from patients with hematolo...
What is the current status of trial NCT00918658?
This trial is currently terminated. The enrollment target is 34 participants. The study started on 2008-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00918658?
The interventions under investigation include: biologic sample preservation procedure (OTHER), laboratory biomarker analysis (OTHER), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00918658?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.